SR-9009 was developed by Professor Thomas Burris of the Scripps Research Institute. It is an agonist of Rev-ErbA (ie. increases the constitutive repression of genes regulated by Rev-ErbA). In mice, it has been shown to increase exercise capacity as well as metabolism and muscle development.



Reviews
There are no reviews yet.